$INDP

Indaptus Therapeutics Advances In Clinical Trials And Expands Intellectual Property Portfolio

$INDP Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical stage biotechnology company, has recently disclosed its financial outcomes for the first quarter…